HIGHLIGHTS
- who: Maurizio Del Poeta et al. from the Brook University have published the research work: Host populations, challenges, and commercialization of cryptococcal vaccines, in the Journal: (JOURNAL)
SUMMARY
Since the first clinical use of vaccines in the late 18th century, many vaccines have been successfully developed to combat bacterial and viral infections, including the most recent Coronavirus Disease 2019 (COVID-19) pandemic. There remains no vaccine that is clinically available to treat or prevent invasive fungal diseases, including cryptococcal meningoencephalitis. Compared to C. neoformans, C. gattii is more commonly isolated in tropical or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.